Philadelphia, United States
The Greenhouse Fund of BioAdvance extends funding to pioneering life sciences startups situated in the Southeastern areas of Pennsylvania. With a focus on human health, they invest in diverse areas like diagnostics, therapeutics, platform technologies, and devices. Over the years, BioAdvance has emerged as a top player in pre-seed and seed-stage funding, having directed $19.6 million for 29 seed-stage companies and 15 pre-seed startups since its first investment in 2003.
90
Total Investments
43
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Financial Services
Funding Stage
Seed +2
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About BioAdvance
Recent Investments (90)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Early VC | •••••• | Nov 2023 | |
| Series A | •••••• | Jul 2023 | |
| Series D | •••••• | Jan 2023 | |
| Seed Round | •••••• | Dec 2022 | |
| Series A | •••••• | Sep 2022 | |
•••• ••••
|
Seed Round | •••••• | Jul 2022 |
|
•••• ••••
|
Series C | •••••• | Jul 2022 |
|
•••• ••••
|
Series A | •••••• | Mar 2022 |
|
•••• ••••
|
Series A | •••••• | Jun 2020 |
|
•••• ••••
|
Series C | •••••• | May 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
